Researcher Next
Create account
← Back to directory

Tetsuya Mitsudomi

Researcher Next ID · RN-004840

Researcher · Medicine

Izumi City General Hospital

Osaka, Japan

Sign in to saveSign in to claim
Not currently recruitingFunding unknown
Works count
1,022
Citation count
62,269
H-index
113
i10-index
420

Research interests

Medicine
Lung Cancer Treatments and Mutations
Lung Cancer Diagnosis and Treatment
Lung Cancer Research Studies
HER2/EGFR in Cancer Research
Gastric Cancer Management and Outcomes

Publications

  • Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial

    The Lancet · 2022 · https://doi.org/10.1016/s0140-6736(21)02333-3

  • International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

    Journal of Thoracic Oncology · 2011 · https://doi.org/10.1097/jto.0b013e318206a221

  • Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial

    The Lancet Oncology · 2009 · https://doi.org/10.1016/s1470-2045(09)70364-x

  • MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling

    Science · 2007 · https://doi.org/10.1126/science.1141478

  • Reduced Expression of the let-7 MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival

    Cancer Research · 2004 · https://doi.org/10.1158/0008-5472.can-04-0637

Current projects

    No projects listed.